Dapagliflozin attenuates early markers of diabetic nephropathy in fructosestreptozotocin- induced diabetes in rats

Citation:
El-Yamany, M. F., M. A. Oraby, M. M. Safar, N. A. G. L. A. A. ASSAF, and H. A. Ghoneim, "Dapagliflozin attenuates early markers of diabetic nephropathy in fructosestreptozotocin- induced diabetes in rats", Biomedicine & Pharmacotherapy, vol. 109, pp. 910-920, 2019.